v3.25.2
Disaggregated Revenues (Tables)
 6 Months Ended
Jun. 30, 2025
Disaggregation of Revenue [Abstract]  
Schedule of Disaggregation of Revenues
The following table provides information regarding total revenues (dollars in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
(unaudited)(unaudited)
Net product sales
Qelbree$77,547 $59,395 $142,292 $104,499 
GOCOVRI36,660 31,703 67,349 58,265 
APOKYN12,820 17,295 27,796 33,944 
Trokendi XR11,193 17,086 23,994 33,075 
Oxtellar XR11,637 29,516 21,835 56,459 
ONAPGO1,604 — 1,604 — 
Other(1)
6,534 7,543 15,113 14,757 
Total net product sales157,995 162,538 299,983 300,999 
Royalty, licensing and other revenues7,458 5,787 15,294 10,970 
Total revenues$165,453 $168,325 $315,277 $311,969 
___________________________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.